A series of thermally stable N-heterocyclic copper-chalcogenolate complexes of the general formula [(IPr)Cu-ESiMe3] (IPr = 1,3-bis(2,6-diisopropylphenyl)imidazolin-2-ylidene; E = S, Se, Te) have been prepared from [(IPr)CuOAc] and E(SiMe3)2 at low temperature. The reaction of [(IPr)Cu-SSiMe3] with mercuric(II) acetate affords the heterometallic [{(IPr)CuS}2Hg] complex containing two (IPr)Cu-S(-) fragments to a central Hg(II).
We explore the effect of π-π interactions in the complexes of mercury halides containing the N-(naphthyl)-2pyrazine carboxamide ligand (L1) in the coordination geometry of the central metal. Results show molecular packing features have a dramatic effect on coordination geometries and that the π-π stacking interaction affects the geometry around the mercury.
A bidentate nitrogen-donor ligand with an appended phenol group, CHNCH[double bond, length as m-dash]N-2-CHOH, H(L1) was treated with a palladium cycloneophyl complex [Pd(CHCMeCH)(COD)], with both Pd-aryl and Pd-alkyl bonds, to give a Pd-alkyl complex, [Pd(CHCMeCH)(κ-N,N',O-OCHN[double bond, length as m-dash]CH(2-CHN))], 1. The cleavage of the Pd-aryl bond and the deprotonation of the ligand phenol to afford a bound aryloxide, indicates facile Pd-aryl bond protonolysis. Deuterium labelling experiments confirmed that the ligand phenol promotes protonolysis and that the reverse, aryl C-H activation, occurs under very mild reaction conditions (within 10 min at room temperature). An unusual isomerization of the Pd-alkyl complex 1 to a Pd-aryl complex, [Pd(CH(2-t-Bu))(κ-N,N',O-OCHN[double bond, length as m-dash]CH(2-CHN))], 2, was observed to give an equilibrium with [2]/[1] = 9 after 5 days in methanol. The isomerization requires that both aryl C-H activation and Pd-alkyl protonolysis steps occur. The very large KIE value (k/k = ca. 40) for isomerization of 1 to 2, suggests a concerted S2-type mechanism for the Pd-alkyl protonolysis step.
A ferrocene-based dithiol 1,1'-[fc(C{O}OCH2CH2SH)2] has been prepared and treated with a Ag(I) salt to form the stable dithiolate compound [fc(C{O}OCH2CH2SAg)2]n (fc=[Fe(η(5)-C5H4)2]). This is used as a reagent for the preparation of the nanocluster [Ag74S19(dppp)6(fc(C{O}OCH2CH2S)2)18] which was obtained in good yield (dppp=1,3-bis(diphenylphosphino)propane).
The
ligand N(CH2-2-C5H4N)2(CH2CH2CH2OH), L1,
reacted with [Pd(CH2CMe2C6H4)(COD)] to give a new fluxional “cycloneophyl”
organopalladium complex [Pd(CH2CMe2C6H4)(κ2-L1)], 1, which on attempted recrystallization from THF gave the monodentate
carbonate complex [Pd(CO3)(κ3-L1)], 2. Complex 2 was prepared in designed
syntheses by reaction of [PdCl(κ3-L1)]+ with silver carbonate or by reaction of [Pd(OH)(κ3-L1)]+ with CO2. Complex 1 reacted with aqueous CO2 to give the cationic
neophylpalladium complex [Pd(CH2CMe2C6H5)(κ3-L1)]+(HCO3)−, 6. Complex 6 reacts with hydrogen peroxide to give complex 2 with
release of a mixture of organic products, the major one being 2-phenyl-2-butanol, PB. The formation of PB involves a neophyl rearrangement
with the unprecedented preference for methyl over phenyl migration.
A mechanistic basis for this unexpected reaction is proposed, involving
β-carbon elimination at a palladium(IV) center.
As a part of efforts to prepare new "metallachalcogenolate" precursors and develop their chemistry for the formation of ternary mixed-metal chalcogenide nanoclusters, two sets of thermally stable, N-heterocyclic carbene metal-chalcogenolate complexes of the general formula [(IPr)Ag-ESiMe3] (IPr=1,3-bis(2,6-diisopropylphenyl)imidazolin-2-ylidene; E=S, 1; Se, 2) and [(iPr2-bimy)Cu-ESiMe3]2 (iPr2-bimy=1,3-diisopropylbenzimidazolin-2-ylidene; E=S, 4; Se, 5) are reported. These are prepared from the reaction between the corresponding carbene metal acetate, [(IPr)AgOAc] and [(iPr-bimy)CuOAc] respectively, and E(SiMe3 )2 at low temperature. The reaction of [(IPr)Ag-ESiMe3] 1 with mercury(II) acetate affords the heterometallic complex [{(IPr)AgS}2Hg] 3 containing two (IPr)Ag-S(-) fragments bonded to a central Hg(II), representing a mixed mercury-silver sulfide complex. The reaction of [(iPr2-bimy)Cu-SSiMe3]2, which contains a smaller N-heterocyclic-carbene, with mercuric(II) acetate affords the high nuclearity cluster, [(iPr2-bimy)6Cu10S8Hg3]6. The new N-heterocyclic carbene metal-chalcogenolate complexes 1, 2, 4, 5 and the ternary mixed-metal chalcogenolate complex 3 and cluster 6 have been characterized by multinuclear NMR spectroscopy ((1)H and (13)C), elemental analysis and single-crystal X-ray diffraction.
A new
route to cycloneophylplatinum(II) complexes is reported and
the selectivity of protonolysis of the platinum–aryl and −alkyl
bonds has been determined. Reaction of [PtCl2(SMe2)2] with neophylmagnesium chloride gives the binuclear
cycloneophylplatinum(II) complex [Pt2(CH2CMe2C6H4)2(μ-SMe2)2], 1, which is shown to exist as a mixture
of syn and anti isomers. Complex 1 reacts reversibly with SMe2 to give [Pt(CH2CMe2C6H4)(SMe2)2], 2, and irreversibly with bidentate ligands
NN = 3,4,7,8-tetramethyl-1,10-phenanthroline (phen*) or 4,4′-di-t-butyl-2,2’bipyridine (bubipy) to give the corresponding
complexes [Pt(CH2CMe2C6H4)(phen*)], 3, and [Pt(CH2CMe2C6H4)(bubipy)], 4, respectively. Complex 2 reacts with HCl initially by cleavage of the aryl–platinum
bond to give mostly trans-[PtCl(CH2CMe2Ph)(SMe2)2], which then rearranges to
an equilibrium mixture with trans-[PtCl(C6H4-2-t-Bu)(SMe2)2], while 3 and 4 react to give [PtCl(CH2CMe2Ph)(phen*)] and [PtCl(CH2CMe2Ph)(bubipy)], which do not undergo the isomerization reaction.
The protonolysis reactions occur by way of a platinum(IV) hydride
complex in each case, and the unusual reactivity of complex 2 is attributed to the ease of dissociation of the Me2S ligands.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.